Your browser doesn't support javascript.
loading
Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial.
Ulander, Lotta; Tolppanen, Heli; Hartman, Otto; Rissanen, Tuomas T; Paakkanen, Riitta; Kuusisto, Jouni; Anttonen, Olli; Nieminen, Tuomo; Yrjölä, Jaana; Ryysy, Ransu; Drews, Teemu; Utriainen, Seppo; Karjalainen, Pasi; Anttila, Ismo; Nurmi, Katariina; Silventoinen, Kristiina; Koskinen, Miika; Kovanen, Petri T; Lehtonen, Jukka; Eklund, Kari K; Sinisalo, Juha.
Afiliação
  • Ulander L; Heart and Lung Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
  • Tolppanen H; Heart and Lung Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
  • Hartman O; Heart and Lung Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
  • Rissanen TT; Heart Center, North Karelia Central Hospital, Siunsote, Joensuu, Finland.
  • Paakkanen R; Heart and Lung Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
  • Kuusisto J; Heart and Lung Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
  • Anttonen O; Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
  • Nieminen T; Department of Internal Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
  • Yrjölä J; Department of Internal Medicine, Kymenlaakson Central Hospital, Kotka, Finland.
  • Ryysy R; Department of Internal Medicine, Kymenlaakson Central Hospital, Kotka, Finland.
  • Drews T; Department of Internal Medicine, South Karelia Central Hospital, Lappeenranta, Finland.
  • Utriainen S; Department of Internal Medicine, South Karelia Central Hospital, Lappeenranta, Finland.
  • Karjalainen P; Heart and Lung Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
  • Anttila I; Department of Internal Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.
  • Nurmi K; Department of Rheumatology, Helsinki University Hospital, Helsinki University, ORTON Orthopaedic Hospital of the Orton Foundation, Helsinki, Finland.
  • Silventoinen K; Department of Rheumatology, Helsinki University Hospital, Helsinki University, ORTON Orthopaedic Hospital of the Orton Foundation, Helsinki, Finland.
  • Koskinen M; Helsinki Biobank, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
  • Kovanen PT; Wihuri Research Institute, Biomedicum, Helsinki, Finland.
  • Lehtonen J; Heart and Lung Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland.
  • Eklund KK; Department of Rheumatology, Helsinki University Hospital, Helsinki University, ORTON Orthopaedic Hospital of the Orton Foundation, Helsinki, Finland.
  • Sinisalo J; Heart and Lung Center, Helsinki University Hospital, Helsinki University, Helsinki, Finland. Electronic address: juha.sinisalo@hus.fi.
Int J Cardiol ; 337: 21-27, 2021 Aug 15.
Article em En | MEDLINE | ID: mdl-33961943
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Holanda